Press Releases

HELSINKI, Dec. 17, 2019 /PRNewswire/ -- Herantis Pharma Plc ("Herantis" or "Company") announced today that patient recruitment in the Company's Phase 2 clinical trial AdeLE ("Adenoviral gene therapy for the treatment of LymphEdema") has been completed. All of the 39 patients with breast cancer associated lymphedema have been randomized to receive either Lymfactin

MELBOURNE, Australia, Dec. 16, 2019 /PRNewswire/ -- Antisense Therapeutics ("ANP" or the "Company") is pleased to advise that the data from all nine participants having completed their 24 weeks of dosing in the Phase II clinical trial of ANP's immunomodulatory therapy, ATL1102 for Duchenne Muscular Dystrophy (DMD) has affirmed the drug's excellent safety profile and

TRENTON, N.J., Dec. 16, 2019 /PRNewswire/ -- In a big victory for New Jersey citizens and medical and religious freedom, the State's Senate failed in its attempts to pass a new bill that would have eliminated religious exemptions for vaccinations, according to non-profit Informed Consent Action Network (ICAN).

CHICAGO, Dec. 16, 2019 /PRNewswire/ -- "Today, the American Heart Association issued a new Science Advisory on the Dietary Cholesterol and Cardiovascular Risk, confirming where the Dietary Guidelines Advisory Committee landed in 2015: dietary cholesterol is not a nutrient of concern and that eggs can be beneficial part of a healthy diet.

NEW YORK, Dec. 16, 2019 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) today announced that it has successfully closed its first green bond offering of $500 million of senior notes due February 2027.  The proceeds will be used to fund renewable energy, water conservation, energy efficiency, and green building projects in compliance with th

LOS ANGELES, Dec. 16, 2019 /PRNewswire/ -- Milstein, Jackson, Fairchild & Wade, LLP of Los Angeles, CA and Heideman Nudelman & Kalik, PC of Washington, DC announce that a proposed settlement has been reached with Johnson & Johnson Services, Inc. and Johnson & Johnson Consumer Inc. ("JJ

NANJING, China, Dec. 16, 2019 /PRNewswire/ -- TransThera Biosciences Co. Ltd, a clinical-stage biotechnology company based in Nanjing, China, announced today that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) appli

LAGUNA HILLS, Calif., Dec. 16, 2019 /PRNewswire/ -- Adagio Medical, Inc. (Adagio) today announced it has enrolled the first patient in its iCLAS™ Investigational Device Exemption (IDE) trial.  The FDA approved study aims to evaluate the safety and efficacy of Adagio's ultra-low temperature intelligent Continuous Lesion Ablation

WASHINGTON, Dec. 16, 2019 /PRNewswire/ -- By raising the federal tobacco age to 21 without also prohibiting flavored e-cigarettes, the budget agreement announced today in Congress will not stop the youth e-cigarette epidemic. If it shifts attention from efforts to ban flavored e-cigarettes, it will play into the hands of tobacco companies Altria and Juul, which have supp

Overall response rate (ORR) of 31% with 2.5 mg/kg regimen and no new safety signals in heavily pre-treated patient population who were refractory to an immunomodulatory drug and a proteasome inhibitor, and were refractory or intolerant to an anti-CD38 antibody Data published in The Lancet Oncology highlight the potential of belantamab mafodotin for patients with